Kimelman & Baird Cut Bristol Myers Squibb Co (BMY) Stake By $495,000; Timberland Bancorp (TSBK)’s Sentiment Is 2

December 13, 2017 - By Linda Rogers

Kimelman & Baird Llc decreased Bristol Myers Squibb Co (BMY) stake by 13.28% reported in 2017Q2 SEC filing. Kimelman & Baird Llc sold 9,000 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The Kimelman & Baird Llc holds 58,748 shares with $3.27M value, down from 67,748 last quarter. Bristol Myers Squibb Co now has $103.94 billion valuation. The stock increased 0.36% or $0.225 during the last trading session, reaching $63.505. About 2.79 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since December 13, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Timberland Bancorp, Inc. operates as the bank holding firm for Timberland Bank that provides various banking services in Washington. The company has market cap of $208.58 million. It offers various deposit products, including money market deposit accounts, checking accounts, regular savings accounts, and certificates of deposit. It has a 14.86 P/E ratio. The firm also provides one-to four-family residential, multi-family, commercial mortgage, construction, custom and owner/builder construction, speculative one- to four-family construction, commercial construction, multi-family construction, land development construction, and land loans.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on January, 25. They expect $0.67 EPS, up 6.35% or $0.04 from last year’s $0.63 per share. BMY’s profit will be $1.10B for 23.70 P/E if the $0.67 EPS becomes a reality. After $0.75 actual EPS reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts -10.67% negative EPS growth.

Investors sentiment increased to 1.03 in 2017 Q2. Its up 0.08, from 0.95 in 2017Q1. It is positive, as 78 investors sold BMY shares while 520 reduced holdings. 120 funds opened positions while 451 raised stakes. 1.10 billion shares or 2.26% less from 1.12 billion shares in 2017Q1 were reported. Tnb Fincl reported 0.19% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Proshare Advsr Lc reported 233,052 shares. Texas-based Salient Advsrs Ltd Llc has invested 0.01% in Bristol-Myers Squibb Company (NYSE:BMY). Mutual Of Omaha Bancorp Wealth Mgmt invested in 0.65% or 34,550 shares. Mechanics Commercial Bank Tru Department owns 118,907 shares or 1.58% of their US portfolio. Coastline, a Rhode Island-based fund reported 26,830 shares. Evergreen Cap Management Lc stated it has 0.05% in Bristol-Myers Squibb Company (NYSE:BMY). Peak6 Investments Limited Partnership, a Illinois-based fund reported 6,450 shares. Cypress Mgmt Ltd Llc (Wy) accumulated 3,270 shares or 0% of the stock. Walleye Trading Ltd Liability Corp has invested 0.03% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Mitsubishi Ufj Securities, a Japan-based fund reported 900 shares. Meiji Yasuda Asset Mgmt, Japan-based fund reported 48,834 shares. The Washington-based Washington Tru Bancorporation has invested 0.07% in Bristol-Myers Squibb Company (NYSE:BMY). Redwood Invests Limited Liability owns 0% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 19 shares. World Asset Mgmt, a Michigan-based fund reported 150,244 shares.

Since September 6, 2017, it had 0 insider purchases, and 1 insider sale for $560,400 activity. On Wednesday, September 6 the insider Caldarella Joseph C sold $560,400.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Friday, September 9 by Barclays Capital. The firm earned “Hold” rating on Thursday, July 27 by Piper Jaffray. The rating was downgraded by Jefferies on Monday, October 16 to “Hold”. Deutsche Bank maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Monday, July 17. Deutsche Bank has “Hold” rating and $55 target. The firm earned “Underweight” rating on Monday, August 24 by Piper Jaffray. The firm has “Equal Weight” rating given on Tuesday, December 1 by Barclays Capital. Citigroup maintained the stock with “Buy” rating in Wednesday, October 25 report. The firm has “Neutral” rating given on Monday, May 23 by Hilliard Lyons. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Market Perform” rating by BMO Capital Markets on Wednesday, April 5. Jefferies maintained the stock with “Hold” rating in Tuesday, June 14 report.

The stock increased 4.66% or $1.27 during the last trading session, reaching $28.54. About 13,407 shares traded. Timberland Bancorp, Inc. (TSBK) has risen 56.96% since December 13, 2016 and is uptrending. It has outperformed by 40.26% the S&P500.

Cutler Capital Management Llc holds 3.54% of its portfolio in Timberland Bancorp, Inc. for 287,949 shares. Westport Asset Management Inc owns 134,513 shares or 2.92% of their US portfolio. Moreover, Zpr Investment Management has 0.82% invested in the company for 21,213 shares. The Texas-based Bridgeway Capital Management Inc has invested 0.03% in the stock. Delta Asset Management Llc Tn, a Tennessee-based fund reported 8,800 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com